Heart Disease Trial, Recruiting NCT07656259 Sponsor: Mayo Clinic Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07656259
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been admitted to a cardiac intensive care unit and need a breathing machine (mechanical ventilator) for more than 12 hours

The trial also includes specific subgroups for additional research questions. These include people with:

  • A serious heart condition called cardiogenic shock (classified as SCAI Stages C, D, or E — confirm with trial site for details)
  • Use of a mechanical heart support device, such as an intra-aortic balloon pump or a small pump inserted into the heart (such as an Impella device)
  • A weakened heart where the heart is pumping less effectively than normal (ejection fraction below 40%)
  • Moderate to severe problems with the right side of the heart not pumping well enough
  • Moderate to severe high blood pressure in the lungs (pulmonary hypertension), as defined by major cardiology guidelines

Who may not be able to join:

  • People whose breathing machine use is expected to last less than 12 hours
  • People with severe chronic lung disease (severe COPD), an abnormal connection between the airways and chest cavity (bronchopleural fistula), or a severe form of lung failure called ARDS (confirm with trial site for technical details)
  • People who already use a breathing machine at home or have a permanent breathing tube in their throat (chronic tracheostomy)
  • People who are pregnant, currently incarcerated, or receiving a life-support treatment that circulates blood outside the body (ECMO)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
28 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherance to assigned study mode (Feasibility Outcome); Time From Enrollment to Initiation of Assigned Mode of Mechanical Ventilation (Feasibility Outcome)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov